| Jump to: | Authorized Access | | | Attribution | | | Authorized Requests |
- Study Description
-
Important Links and Information
-
Request access via Authorized Access
- Instructions for requestors
- Data Use Certification (DUC) Agreement
- Talking Glossary of Genetic Terms
We performed germline whole-genome sequencing from peripheral blood of individuals carrying the EGFR T790M variant (n=53) and those who do not (n=206). This data is subset to chromosome 7 for all participants. For more information on study protocol please see NCT05587439.
- Study Design:
- Case-Control
- Study Type:
- Case Set
- Cohort
- Control Set
- Individual-Level Genomic Data
- dbGaP estimated ancestry using GRAF-pop
- Total number of consented subjects: 259
- Subject Sample Telemetry Report (SSTR)
-
Request access via Authorized Access
- Authorized Access
- Publicly Available Data
- Link to other NCBI resources related to this study
-
- BioProject
- Gene
- Clinical Trials
- Study Inclusion/Exclusion Criteria
Personal or family history of lung cancer
- Selected Publications
- Diseases/Traits Related to Study (MeSH terms)
-
- Primary Phenotype: Lung neoplasms
- Links to Related Genes
- Authorized Data Access Requests
- Study Attribution
-
-
Principal Investigator
- Jaclyn LoPiccolo, MD, PhD. Dana-Farber Cancer Institute, Boston, MA, USA.
-
Co-Investigators
- Pasi A. Janne, MD, PhD. Dana-Farber Cancer Institute, Boston, MA, USA.
- Alexander Gusev, PhD. Dana-Farber Cancer Institute, Boston, MA, USA.
- Judy E. Garber, MD. Dana-Farber Cancer Institute, Boston, MA, USA.
-
Sequencing Center
- Broad Clinical Labs. Broad Institute, Boston, MA, USA.
-
Funding Source
- GO2 for Lung Cancer. Washington, DC, USA.
-
Principal Investigator